510(k) K013180
K013180 is an FDA 510(k) premarket notification submitted by American Bio Medica Corp. for the device "RAPIDONE-ECSTASY TEST". The FDA issued a decision of Substantially Equivalent on November 26, 2001. The device falls under product code DJC (Thin Layer Chromatography, Methamphetamine), a Class II device regulated under 21 CFR 862.3610. American Bio Medica Corp. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- November 26, 2001
- Date Received
- September 24, 2001
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Thin Layer Chromatography, Methamphetamine
- Device Class
- Class II
- Regulation Number
- 862.3610
- Review Panel
- TX
- Submission Type